...Chester Carlson was a patent agent who tired of having to make multiple copies of patent applications using the only duplication method available at the time: carbon paper. In 1959 he came up with a new copying system and took it to IBM for evaluation. The "experts" at IBM determined potential sales to be only 5,000 units because people wouldn't want to use a bulky machine when they had carbon paper. Carlson's invention was the xerography process, the company founded on the system is Xerox.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8153804 | Aryl pyridines and methods of their use Aryl pyridines, compositions comprising them, and methods of their use for the treatment, prevention and management of a variety of diseases and disorders are disclosed. ... | 04/10/2012 |
| 8093291 | Methods of using and compositions comprising tryptophan hydroxylase inhibitors Methods and compositions comprising tryptophan hydroxylase inhibitors are disclosed. Particular methods are directed at reducing or avoiding serotonin-mediated adverse effects associated with some drugs. ... | 01/10/2012 |
| 8093280 | Methods of preparing imidazole-based compounds Methods of preparing imidazole-based compounds are disclosed. Particular compounds are of formula I. ... | 01/10/2012 |
| 8093267 | Methods of treating rheumatoid arthritis Imidazole-based compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of inflammatory and autoimmune diseases and disorders are disclosed. Particular compounds are of formula I: | 01/10/2012 |
| 8093246 | O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer O-linked pyrimidin-4-amine-based compounds, pharmaceutical compositions comprising them, and methods of their use are described. Particular compounds of the invention are of formula I: ... | 01/10/2012 |
| 8093245 | 4-amino-1H-pyrimidin-2-one based compounds, compositions comprising them and methods of their use 4-Amino-1H-pyrimidin-2-one-based compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of various diseases and disorders are disclosed. Particular compounds are of formula I: | 01/10/2012 |
| 8092796 | Monoclonal antibodies against ANGPTL4 Monoclonal antibodies that specifically bind to ANGPTL4 are provided. Monoclonal antibodies that neutralize at least one activity of ANGPTL4 are provided. Methods of treating a disorder of lipid metabolism using neutralizing monoclonal antibodies are provided. ... | 01/10/2012 |
| 8063057 | Multicyclic amino acid derivatives and methods of their use Compounds of formulae I and II are disclosed, as well as compositions comprising them and methods of their use to treat, prevent and manage serotonin-mediated diseases and disorders: ... | 11/22/2011 |
| 8026347 | Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors Methods of synthesizing sodium glucose co-transporter 2 inhibitors, as well as compounds useful therein, are disclosed. Particular inhibitors are compounds of formula I: ... | 09/27/2011 |
| 7998994 | Solid forms of (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use Solid forms of (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol and hydrates thereof are disclosed, as well as compositions comprising them and methods of their use. ... | 08/16/2011 |
| 7968729 | 1-phenyl-1H-pyrazole-based compounds Methods useful for preparing compounds of formula I: and salts thereof are disclosed. Also disclosed are intermediates useful in the preparation of such compounds. ... | 06/28/2011 |
| 7968726 | Methods of preparing imidazole-based bicyclic compounds Methods of preparing compounds of formula I are disclosed: ... | 06/28/2011 |
| 7968559 | Methods of using 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds Compounds of formula I are disclosed, as well as compositions comprising them and methods of their use to treat, prevent and/or manage diseases and disorders: ... | 06/28/2011 |
| 7951941 | Process for preparing 5-alkyl-7H-pyrrolo[2,3-d] pyrimindine-2-ols Methods of preparing 5-alkyl-7H-pyrrolo[2,3-d]pyrimidin-4-ols are described, as are novel compounds useful in their preparation. A specific method encompassed by the invention is represented in the following scheme: ... | 05/31/2011 |
| 7935796 | Monoclonal antibodies against ANGPTL3 Monoclonal antibodies that specifically bind to ANGPTL3 are provided. Monoclonal antibodies that neutralize at least one activity of ANGPTL3 are provided. Methods of treating a disorder of lipid metabolism using neutralizing monoclonal antibodies are provided. ... | 05/03/2011 |
| 7919618 | Synthesis of piperazines, piperidines and related compounds Novel methods of synthesizing piperazines, piperidines and related compounds are disclosed, as are compounds useful for their preparation. ... | 04/05/2011 |
| 7897763 | Process for the preparation of substituted phenylalanines Intermediates and synthetic processes for the preparation of substituted phenylalanine-based compounds (e.g., of Formula I) are disclosed: ... | 03/01/2011 |
| 7846945 | Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use Compounds and pharmaceutical compositions comprising them are disclosed that may be useful for the treatment of diseases and disorders such as diabetes and obesity. ... | 12/07/2010 |
| 7875622 | Methods and compositions for treating pulmonary hypertension and related diseases and disorders Methods of treating pulmonary hypertension are disclosed. Particular methods comprise the administration of a tryptophan hydroxylase inhibitor and at least one other active pharmaceutical ingredient to patient in need thereof. Pharmaceutical formulations are also di... | 01/25/2011 |
| 7855291 | Process for the preparation of substituted phenylalanines Intermediates and synthetic processes for the preparation of substituted phenylalanine-based compounds (e.g., of Formula I) are disclosed: ... | 12/21/2010 |
| 7825150 | Compositions and methods for treating immunological and inflammatory diseases and disorders Methods and compositions for treating immunological and inflammatory diseases and disorders are disclosed. Particular methods and compositions comprise the administration of an agent that inhibits S1P lyase activity and at least one additional immunosuppressive and/... | 11/02/2010 |
| 7825142 | Heterocyclic compounds, compositions comprising them and methods of their use Heterocyclic compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of inflammatory and autoimmune diseases and disorders are disclosed. Particular compounds are of formula I: | 11/02/2010 |
| 7812174 | Methods of preparing imidazole-based compounds Methods of preparing imidazole-based compounds are disclosed. Particular compounds are of formula I: ... | 10/12/2010 |
| 7781577 | Inhibitors of sodium glucose co-transporter 2 and methods of their use Compounds and pharmaceutical compositions comprising them are disclosed that may be useful for the treatment of diseases and disorders such as diabetes and obesity. ... | 08/24/2010 |
| 7723345 | Multicyclic amino acid derivatives and methods of their use Compounds of formulae I and II are disclosed, as well as compositions comprising them and methods of their use to treat, prevent and manage serotonin-mediated diseases and disorders: ... | 05/25/2010 |
| 7709493 | 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use Compounds of formula I are disclosed, as well as compositions comprising them and methods of their use to treat, prevent and/or manage diseases and disorders: ... | 05/04/2010 |
| 7655762 | Monoclonal antibodies against ANGPTL4 Monoclonal antibodies that specifically bind to ANGPTL4 are provided. Monoclonal antibodies that neutralize at least one activity of ANGPTL4 are provided. Methods of treating a disorder of lipid metabolism using neutralizing monoclonal antibodies are provided. ... | 02/02/2010 |
| 7649098 | Imidazole-based compounds, compositions comprising them and methods of their use Imidazole-based compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of inflammatory and autoimmune diseases and disorders are disclosed. Particular compounds are of formula I: | 01/19/2010 |
| 7598280 | Heterocyclic compounds, compositions comprising them and methods of their use Heterocyclic compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of inflammatory and autoimmune diseases and disorders are disclosed. Particular compounds are of formula I: | 10/06/2009 |
| 7553840 | 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use Compounds of formula I are disclosed, as well as compositions comprising them and methods of their use to treat, prevent and/or manage diseases and disorders: ... | 06/30/2009 |
| 7423043 | 4-Piperidin-1-yl-7-pyrrolo[2,3-]pyrimidine compounds Substituted 4-piperidin-1-yl-7H-pyrrolo[2,3-D]pyrimidine compounds are disclosed, as well as compositions comprising them and methods of their use for the treatment, prevention and management of various diseases and disorders. ... | 09/09/2008 |
| 7402730 | Knockout animals manifesting hyperlipidemia Genetically engineered cells and animals are described that incorporate a mutated GHP1 allele. Animals that are homozygous for the mutated GHP1 allele are useful for the production of monoclonal antibodies against GHP1. ... | 07/22/2008 |
| 7374933 | Human metalloprotease and polynucleotides encoding the same Novel human polynucleotide and polypeptide sequences are disclosed that can be used in thereapeutic, diagnostic, and pharmacogenomic applications. ... | 05/20/2008 |
| 7374932 | Human kinases and polynucleotides encoding the same, and uses thereof Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications. ... | 05/20/2008 |
| 7332338 | Vectors for making genomic modifications Methods and vectors (both DNA and retroviral) are provided for the construction of a Library of mutated cells. The Library will preferably contain mutations in essentially all genes present in the genome of the cells. The nature of the Library and the vectors allow ... | 02/19/2008 |
| 7312079 | Variants of FAM3C Polynucleotide and polypeptide sequences that encode novel variant FAM3C proteins are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications. ... | 12/25/2007 |
| 7300949 | Thiazolopyrazoles and methods of their use This invention concerns novel thiazolopyrazole compounds and compositions comprising them. Methods of using these compounds for the treatment, prevention and management of various diseases and disorders are also encompassed by the invention. ... | 11/27/2007 |
| 7268222 | Polynucleotides encoding human transporter proteins Novel human ATP binding cassette transporter polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications. ... | 09/11/2007 |
| 7229790 | Human GABA transporter protein and polynucleotides encoding the same Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications. ... | 06/12/2007 |